|
1
|
Haris K, Ismail S, Idris Z, Abdullah JM
and Yusoff AA: Expression profile of genes modulated by Aloe emodin
in human U87 glioblastoma cells. Asian Pac J Cancer Prev.
15:4499–4505. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JH, Jung TY, Jung S, Kim IY, Jang WY,
Moon KS and Jeong EH: Performance status during and after
radiotherapy plus concomitant and adjuvant temozolomide in elderly
patients with glioblastoma multiforme. J Clin Neurosci. 20:503–508.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wick W, Weller M, van den Bent M, Sanson
M, Weiler M, von Deimling A, Plass C, Hegi M, Platten M and
Reifenberger G: MGMT testing - the challenges for biomarker-based
glioma treatment. Nat Rev Neurol. 10:372–385. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Errafiy R, Aguado C, Ghislat G, Esteve JM,
Gil A, Loutfi M and Knecht E: PTEN increases autophagy and inhibits
the ubiquitin-proteasome pathway in glioma cells independently of
its lipid phosphatase activity. PLoS One. 8:e833182013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim YC, Roberts TL, Day BW, Harding A,
Kozlov S, Kijas AW, Ensbey KS, Walker DG and Lavin MF: A role for
homologous recombination and abnormal cell-cycle progression in
radio-resistance of glioma-initiating cells. Mol Cancer Ther.
11:1863–1872. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ketting RF: microRNA biogenesis and
function: An overview. Adv Exp Med Biol. 700:1–14. 2011. View Article : Google Scholar
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giraldez AJ, Cinalli RM, Glasner ME,
Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP and
Schier AF: MicroRNAs regulate brain morphogenesis in zebrafish.
Science. 308:833–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Png KJ, Halberg N, Yoshida M and Tavazoie
SF: A microRNA regulon that mediates endothelial recruitment and
metastasis by cancer cells. Nature. 481:190–194. 2012. View Article : Google Scholar
|
|
12
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar
|
|
13
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Corsten MF, Miranda R, Kasmieh R,
Krichevsky AM, Weissleder R and Shah K: MicroRNA-21 knockdown
disrupts glioma growth in vivo and displays synergistic
cytotoxicity with neural precursor cell delivered S-TRAIL in human
gliomas. Cancer Res. 67:8994–9000. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui QK, Liu WD, Zhu JX, Wang YH and Wang
ZG: MicroRNA-184 promotes proliferation ability of glioma cells by
regulating FOXO3. Asian Pac J Trop Med. 7:776–779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu X, Chen D, Cui Y, Li Z and Huang J:
Targeting microRNA-23a to inhibit glioma cell invasion via HOXD10.
Sci Rep. 3:34232013.PubMed/NCBI
|
|
17
|
Ye L, Wang C, Yu G, Jiang Y, Sun D, Zhang
Z, Yu X, Li X, Wei W, Liu P, et al: Bmi-1 induces radioresistance
by suppressing senescence in human U87 glioma cells. Oncol Lett.
8:2601–2606. 2014.PubMed/NCBI
|
|
18
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Murayama S, Kawai R, Hirabuki N, Miura T,
Mitomo M, Kozuka T and Usio Y: Intra-arterial ACNU chemotherapy of
malignant glioma. Nihon Igaku Hoshasen Gakkai Zasshi. 48:144–153.
1988.In Japanese. PubMed/NCBI
|
|
22
|
Taylor LP: Diagnosis, treatment, and
prognosis of glioma: Five new things. Neurology. (18 Suppl
1)75:S28–S32. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Delaney G, Jacob S, Featherstone C and
Barton M: The role of radiotherapy in cancer treatment: Estimating
optimal utilization from a review of evidence-based clinical
guidelines. Cancer. 104:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schmitt CA: Cellular senescence and cancer
treatment. Biochim Biophys Acta. 1775:5–20. 2007.
|
|
26
|
Roninson IB: Tumor cell senescence in
cancer treatment. Cancer Res. 63:2705–2715. 2003.PubMed/NCBI
|
|
27
|
Molofsky AV, He S, Bydon M, Morrison SJ
and Pardal R: Bmi-1 promotes neural stem cell self-renewal and
neural development but not mouse growth and survival by repressing
the p16Ink4a and p19Arf senescence pathways. Genes Dev.
19:1432–1437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
O'Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maher EA, Furnari FB, Bachoo RM, Rowitch
DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics
and biology of a grave matter. Genes Dev. 15:1311–1333. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hara E, Smith R, Parry D, Tahara H, Stone
S and Peters G: Regulation of p16CDKN2 expression and its
implications for cell immortalization and senescence. Mol Cell
Biol. 16:859–867. 1996.PubMed/NCBI
|
|
31
|
Zhang Y, Xiong Y and Yarbrough WG: ARF
promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus
deletion impairs both the Rb and p53 tumor suppression pathways.
Cell. 92:725–734. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Venkataraman S, Alimova I, Fan R, Harris
P, Foreman N and Vibhakar R: MicroRNA 128a increases intracellular
ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer
cell growth by promoting senescence. PLoS One. 5:e107482010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Finkel T: Signal transduction by reactive
oxygen species in non-phagocytic cells. J Leukoc Biol. 65:337–340.
1999.PubMed/NCBI
|
|
34
|
Bauer G: Low dose radiation and
intercellular induction of apoptosis: Potential implications for
the control of oncogenesis. Int J Radiat Biol. 83:873–888. 2007.
View Article : Google Scholar : PubMed/NCBI
|
